Mindrescu, N.M.; Guja, C.; Jinga, V.; Ispas, S.; Curici, A.; Danciulescu Miulescu, R.E.; Nelson Twakor, A.; Pantea Stoian, A.M.
SGLT-2 Inhibitors and Metabolic Outcomes: A Primary Data Study Exploring the Microbiota–Diabetes Connection. Metabolites 2025, 15, 411.
https://doi.org/10.3390/metabo15060411
AMA Style
Mindrescu NM, Guja C, Jinga V, Ispas S, Curici A, Danciulescu Miulescu RE, Nelson Twakor A, Pantea Stoian AM.
SGLT-2 Inhibitors and Metabolic Outcomes: A Primary Data Study Exploring the Microbiota–Diabetes Connection. Metabolites. 2025; 15(6):411.
https://doi.org/10.3390/metabo15060411
Chicago/Turabian Style
Mindrescu, Nicoleta Mihaela, Cristian Guja, Viorel Jinga, Sorina Ispas, Antoanela Curici, Rucsandra Elena Danciulescu Miulescu, Andreea Nelson Twakor, and Anca Mihaela Pantea Stoian.
2025. "SGLT-2 Inhibitors and Metabolic Outcomes: A Primary Data Study Exploring the Microbiota–Diabetes Connection" Metabolites 15, no. 6: 411.
https://doi.org/10.3390/metabo15060411
APA Style
Mindrescu, N. M., Guja, C., Jinga, V., Ispas, S., Curici, A., Danciulescu Miulescu, R. E., Nelson Twakor, A., & Pantea Stoian, A. M.
(2025). SGLT-2 Inhibitors and Metabolic Outcomes: A Primary Data Study Exploring the Microbiota–Diabetes Connection. Metabolites, 15(6), 411.
https://doi.org/10.3390/metabo15060411
